Chimpanzee as model of human benign prostatic hyperplasia

被引:38
|
作者
Steiner, MS
Couch, RC
Raghow, S
Stauffer, D
机构
[1] Univ Tennessee, Med Ctr, Dept Urol, Urol Res Labs, Memphis, TN 38163 USA
[2] Coulston Fdn, White Sands Res Ctr, Alamogordo, NM USA
来源
JOURNAL OF UROLOGY | 1999年 / 162卷 / 04期
关键词
benign prostatic hyperplasia; aging; chimpanzee;
D O I
10.1016/S0022-5347(05)68340-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The etiology and natural history of benign prostatic hyperplasia (BPH), the most common benign disease in aging men, remain obscure. The canine BPH model has serious limitations but other animal BPH models have not been identified. We evaluated whether the chimpanzee, man's closest primate relative, developed spontaneous BPH. Materials and Methods: A cross-sectional analysis of a colony (White Sands Research Center) that contained 700 chimpanzees was undertaken by sampling 63 male and female (controls) chimpanzees 8 to 35 years old. The presence of spontaneous BPH was evaluated by assessing pathological and clinical variables, including prostate volume, serum prostate specific antigen, presence of histological BPH, serum androgens and estradiol, and urodynamics studies. Results: The chimpanzee had evidence of spontaneous histological BPH, and incidence and grade increased with age. Spontaneous BPH was manifested by increased prostate volume, higher serum prostate specific antigen, higher stromal/epithelial ratio and decreased urinary flow rates. As in man, serum androgens did not correlate with BPH in the chimpanzee. Conclusions: Male chimpanzees developed spontaneous histological BPH at the same relative point in their life cycle as humans which resulted clinically in larger prostates and decreased urinary flow rates. Serum hormone levels did not appear to correlate with BPH. A better understanding of the chimpanzee-BPH model may lead to new therapeutic strategies for BPH in man.
引用
收藏
页码:1454 / 1461
页数:8
相关论文
共 50 条
  • [41] Benign Prostatic Hyperplasia
    Langan, Robert C.
    PRIMARY CARE, 2019, 46 (02): : 223 - +
  • [42] Benign prostatic hyperplasia
    Schulze, H
    UROLOGE-AUSGABE A, 1997, 36 (01): : 1 - 2
  • [43] Benign prostatic hyperplasia
    Chughtai, Bilal
    Forde, James C.
    Thomas, Dominique Dana Marie
    Laor, Leanna
    Hossack, Tania
    Woo, Henry H.
    Te, Alexis E.
    Kaplan, Steven A.
    NATURE REVIEWS DISEASE PRIMERS, 2016, 2 : 1 - 15
  • [44] BENIGN PROSTATIC HYPERPLASIA
    FRANKS, LM
    LANCET, 1974, 2 (7875): : 293 - 293
  • [45] Benign prostatic hyperplasia
    Doherty, AP
    HOSPITAL MEDICINE, 2003, 64 (02): : 114 - 114
  • [46] PATHOBIOLOGY OF THE HUMAN PROSTATIC-CARCINOMA AND BENIGN PROSTATIC HYPERPLASIA - AN OVERVIEW
    KRIEG, M
    TUNN, S
    PROGRESS IN ENDOCRINOLOGY 1988, VOL 1 AND 2, 1988, 799 : 287 - 292
  • [47] HISTOCHEMICAL STUDY OF GLYCOSIDASES IN BENIGN PROSTATIC HYPERPLASIA AND IN PROSTATIC CARCINOMA IN HUMAN
    SINOWATZ, F
    WEBER, P
    GASSER, G
    MOSSIG, H
    SKOLEKWINNISCH, R
    UROLOGICAL RESEARCH, 1978, 6 (02): : 103 - 107
  • [48] Prostatic stents for benign prostatic hyperplasia
    Klein, LT
    Kaplan, SA
    JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS, 1997, 7 (01) : 101 - 114
  • [49] DEMONSTRATION OF A PROGESTIN RECEPTOR IN HUMAN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC CARCINOMA
    GUSTAFSSON, JA
    EKMAN, P
    POUSETTE, A
    SNOCHOWSKI, M
    HOGBERG, B
    INVESTIGATIVE UROLOGY, 1978, 15 (05): : 361 - 366
  • [50] PROTEOGLYCANS OF NORMAL HUMAN PROSTATE AND BENIGN PROSTATIC HYPERPLASIA
    WONG, YC
    HUANG, P
    MEI, H
    FASEB JOURNAL, 1994, 8 (04): : A47 - A47